Institutional shares held 166 Million
1.93M calls
1.23M puts
Total value of holdings $11.5B
$134M calls
$85.2M puts
Market Cap $12.3B
176,960,000 Shares Out.
Institutional ownership 93.88%
# of Institutions 636


Latest Institutional Activity in EXAS

Top Purchases

Q3 2024
International Assets Investment Management, LLC Shares Held: 165K ($11.5M)
Q3 2024
Artemis Investment Management LLP Shares Held: 107K ($7.44M)
Q3 2024
Harbor Capital Advisors, Inc. Shares Held: 70.8K ($4.93M)
Q3 2024
Forsta Ap Fonden Shares Held: 38.8K ($2.7M)
Q3 2024
Friedenthal Financial Shares Held: 11.8K ($820K)

Top Sells

Q3 2024
Abrdn PLC Shares Held: 6.54K ($455K)
Q3 2024
Vontobel Holding Ltd. Shares Held: 3.97K ($276K)
Q3 2024
Van Eck Associates Corp Shares Held: 136K ($9.46M)
Q3 2024
New York State Common Retirement Fund Shares Held: 296K ($20.6M)
Q3 2024
Stanley Laman Group, Ltd. Shares Held: 93.6K ($6.51M)

About EXAS

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.


Insider Transactions at EXAS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
352K Shares
From 24 Insiders
Grant, award, or other acquisition 95.7K shares
Exercise of conversion of derivative security 256K shares
Sell / Disposition
173K Shares
From 12 Insiders
Payment of exercise price or tax liability 62.9K shares
Open market or private sale 110K shares

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS